Newsweek sought email comment from the FTC and its outgoing chairwoman, Lina Khan, on Friday. The flurry of lawsuits before the change to a GOP administration underscore the tension within the FTC between pro-regulation Democrats and anti-regulation Republicans.

The U.S. Federal Trade Commission's merger-busting, antitrust enforcement powers are coming under threat as conservatives look to harness President-elect Donald Trump's support for limiting government.

Donald Trump will be inaugurated as the 47th President of the United States on Monday 20 January 2025, marking the beginning of a second term in the Oval Office for the businessman-turned-politician.

The Democratic enforcer significantly expanded the agency’s remit; now the new GOP administration will decide how to follow through.

It takes effect Tuesday but its fate is already in doubt. The new FTC rule faces legal challenges and possible opposition from Trump administration.

Antitrust regulators have reached a deal with Welsh, Carson, Anderson and Stowe that doesn’t penalize the private equity firm for rolling up the market for anesthesia services in Texas, but tries to prevent it from happening again.

Melania Trump said she will be bringing back her 'Be Best' campaign during her second stint as first lady after Donald Trump assumes office

Lina Khan, who was tapped by President Joe Biden to lead the FTC, is set to be replaced by President-elect Donald Trump’s pick Andrew Ferguson.

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.

Many have noticed how differently some business leaders are greeting the second Trump presidency, write Jeffrey Sonnenfeld and Steven Tian

President-elect Donald Trump’s recent appointments and cabinet nominees are pointing to a four-year stint of deregulation in the tech industry, and lots of potential for competitive growth within the industry and globally,

But for all the noise, many Wall Street professionals believe the policy risk in the healthcare sector is lower than feared. “If you combine the fact that Congress is so divided that making policy changes is going to be just incredibly difficult,